Literature DB >> 9257663

Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children.

M J Bell1, P M Kochanek, L A Doughty, J A Carcillo, P D Adelson, R S Clark, S R Wisniewski, M J Whalen, S T DeKosky.   

Abstract

Cytokines may play an important role in the pathophysiology of traumatic brain injury (TBI) in children. Interleukin-6 (IL-6) is a proinflammatory cyotkine that plays a role in regenerative processes within the central nervous system (CNS), whereas interleukin-10 (IL-10) is an antiinflammatory cytokine. Both have been measured in serum and cerebrospinal fluid (CSF) as an index of the degree of inflammation in diseases, including sepsis and meningitis. We hypothesized that both IL-6 and IL-10 would be increased in the CSF of children after severe TBI. Fifteen children who sustained severe TBI (Glascow Coma Score [GCS] < or = 7) were studied. Standard neurointensive care was provided. Ventricular CSF collected the first 3 days after TBI was analyzed for IL-6 and IL-10 concentrations by ELISA. Controls were 20 children who were evaluated for meningitis with diagnostic lumbar puncture subsequently found to have no CSF pleocytosis and negative cultures. IL-6 was increased in children after TBI versus controls on all days studied (day 1, 3158.2 +/- 621.8 pg/ml; day 2, 1111.6 +/- 337.0 pg/ml; day 3, 826.7 +/- 193.5 pg/ml vs. 20.6 +/- 5.8 pg/ml, p < 0.0001, Mann-Whitney Rank Sum). IL-10 was increased in children after TBI vs controls on all days studied (day 1, 47.2 +/- 12.9 pg/ml; day 2, 21.0 +/- 6.7 pg/ml; day 3, 15.5 +/- 5.9 pg/ml vs. 8.9 +/- 7.5 pg/ml, p < 0.01). Increased IL-10 concentrations were independently associated with age < 4 years and mortality (p = 0.004 and 0.04, respectively, multivariate linear model). This study demonstrates that IL-6 is increased after TBI in children to levels similar to those reported in adults and is the first to show that IL-10 is increased in CSF of humans after TBI. These data suggest that there may be an age-dependent production of IL-10 after TBI in children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257663     DOI: 10.1089/neu.1997.14.451

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  72 in total

Review 1.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

Review 2.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 3.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

Review 4.  Therapeutic strategies to target acute and long-term sequelae of pediatric traumatic brain injury.

Authors:  Jimmy W Huh; Ramesh Raghupathi
Journal:  Neuropharmacology       Date:  2018-06-20       Impact factor: 5.250

Review 5.  Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood.

Authors:  Henrik Zetterberg; Douglas H Smith; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2013-02-12       Impact factor: 42.937

6.  YKL-40 expression in traumatic brain injury: an initial analysis.

Authors:  Dafna Bonneh-Barkay; Pavel Zagadailov; Huichao Zou; Christian Niyonkuru; Matthew Figley; Adam Starkey; Guoji Wang; Stephanie J Bissel; Clayton A Wiley; Amy K Wagner
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

7.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

Review 8.  Cerebral Blood Flow Autoregulation and Dysautoregulation.

Authors:  William M Armstead
Journal:  Anesthesiol Clin       Date:  2016-09

9.  Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats.

Authors:  Patrick M Kochanek; C Edward Dixon; David K Shellington; Samuel S Shin; Hülya Bayır; Edwin K Jackson; Valerian E Kagan; Hong Q Yan; Peter V Swauger; Steven A Parks; David V Ritzel; Richard Bauman; Robert S B Clark; Robert H Garman; Faris Bandak; Geoffrey Ling; Larry W Jenkins
Journal:  J Neurotrauma       Date:  2013-06-05       Impact factor: 5.269

10.  COX2 inhibitors for acquired brain injuries: is the time ripe?

Authors:  Kenneth I Strauss
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.